United States Biotechnology & Medical Research

Vir Biotechnology Inc (VIR)

Track

Over the last 90 days, Vir Biotechnology Inc. has seen significant insider selling, with a total sell value of approximately $2.87 million. There were no reported insider purchases. The majority of transactions were planned or proposed sales by directors and officers, occurring across multiple dates in March, April, May, and June 2026.

Not featured in screeners

Featured in screeners

Not featured in screeners

Stock chart

Ticker: VIR Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Napolitano Janet

2 sales — total 60,480 USD

Planned sale 1 Jun 2026

Value US$3,120,488.49 | Price 279.75 | Shares 18,706

Proposed sale 1 Jun 2026

Value US$699,856.16 | Price 93.67 | Shares 49,089

Sabatini Brent

SVP, Chief Accounting Officer

2 sales — total 7,163 USD

Planned sale 1 Jun 2026

Value US$4,309,714.60 | Price 448.32 | Shares 5,417

Proposed sale 1 Jun 2026

Value US$4,968,237.48 | Price 426.18 | Shares 22,071

SATO VICKI L

1 sale — total 221,025 USD

Planned sale 1 May 2026

Value US$221,025.20 | Price 10.05 | Shares 22,000

Eisner Mark

Former Officer

1 sale — total 916,267 USD

Proposed sale 30 Apr 2026

Value US$916,267.40 | Price 10.30 | Shares 88,958

De Backer Marianne

President and CEO

2 sales — total 1,328,693 USD

Planned sale 6 Apr 2026

Value US$664,350.20 | Price 9.16 | Shares 72,559

Proposed sale 6 Apr 2026

Value US$664,342.95 | Price 9.16 | Shares 72,559

SATO VICKI L

1 sale — total 199,617 USD

Planned sale 1 Apr 2026

Value US$199,617.00 | Price 9.07 | Shares 22,000

Sabatini Brent

SVP, Chief Accounting Officer

2 sales — total 140,649 USD

Planned sale 23 Mar 2026

Value US$70,324.32 | Price 9.12 | Shares 7,711

Proposed sale 23 Mar 2026

Value US$70,324.32 | Price 9.12 | Shares 7,711

SATO VICKI L

2 sales — total 209,181 USD

Planned sale 2 Mar 2026

Value US$1,996.00 | Price 9.98 | Shares 200

Planned sale 2 Mar 2026

Value US$207,185.02 | Price 9.50 | Shares 21,800

VICKI LEE SATO

Director

1 sale — total 799,920 USD

Proposed sale 2 Mar 2026

Value US$799,920.00 | Price 9.09 | Shares 88,000

Eisner Mark

EVP and Chief Medical Officer

2 sales — total 37,100 USD

Planned sale 25 Feb 2026

Value US$18,549.98 | Price 9.82 | Shares 1,889

Proposed sale 25 Feb 2026

Value US$18,549.98 | Price 9.82 | Shares 1,889

de Verneuil Vanina

EVP, General Counsel, Corp Sec

2 sales — total 269,068 USD

Planned sale 25 Feb 2026

Value US$134,534.00 | Price 9.82 | Shares 13,700

Proposed sale 25 Feb 2026

Value US$134,534.00 | Price 9.82 | Shares 13,700

SVF Endurance (Cayman) Limited

Stockholder

1 sale — total 3,796,000 USD

Proposed sale 25 Feb 2026

Value US$3,796,000.00 | Price 9.49 | Shares 400,000

O'Byrne Jason

EVP & Chief Financial Officer

2 sales — total 31,153 USD

Planned sale 24 Feb 2026

Value US$15,576.27 | Price 9.53 | Shares 1,634

Proposed sale 24 Feb 2026

Value US$15,576.27 | Price 9.53 | Shares 1,634

SATO VICKI L

2 sales — total 413,366 USD

Planned sale 24 Feb 2026

Value US$2,052.00 | Price 10.26 | Shares 200

Planned sale 24 Feb 2026

Value US$411,314.32 | Price 9.75 | Shares 42,177

Sabatini Brent

SVP, Chief Accounting Officer

2 sales — total 27,263 USD

Planned sale 24 Feb 2026

Value US$13,631.62 | Price 9.53 | Shares 1,430

Proposed sale 24 Feb 2026

Value US$13,631.61 | Price 9.53 | Shares 1,430

Eisner Mark

EVP and Chief Medical Officer

2 sales — total 30,809 USD

Planned sale 24 Feb 2026

Value US$15,404.68 | Price 9.53 | Shares 1,616

Proposed sale 24 Feb 2026

Value US$15,404.68 | Price 9.53 | Shares 1,616

de Verneuil Vanina

EVP, General Counsel, Corp Sec

2 sales — total 59,426 USD

Planned sale 24 Feb 2026

Value US$29,713.11 | Price 9.53 | Shares 3,117

Proposed sale 24 Feb 2026

Value US$29,713.11 | Price 9.53 | Shares 3,117

De Backer Marianne

Chief Executive Officer

2 sales — total 281,440 USD

Planned sale 24 Feb 2026

Value US$140,720.24 | Price 9.53 | Shares 14,762

Proposed sale 24 Feb 2026

Value US$140,720.25 | Price 9.53 | Shares 14,762

VICKI LEE SATO

Director

1 sale — total 151,401 USD

Proposed sale 24 Feb 2026

Value US$151,401.11 | Price 7.43 | Shares 20,377

Sabatini Brent

SVP, Chief Accounting Officer

2 sales — total 27,262 USD

Planned sale 23 Feb 2026

Value US$13,631.17 | Price 7.45 | Shares 1,829

Proposed sale 23 Feb 2026

Value US$13,631.18 | Price 7.45 | Shares 1,829

O'Byrne Jason

EVP & Chief Financial Officer

2 sales — total 31,138 USD

Planned sale 23 Feb 2026

Value US$15,568.90 | Price 7.45 | Shares 2,089

Proposed sale 23 Feb 2026

Value US$15,568.90 | Price 7.45 | Shares 2,089

Eisner Mark

EVP and Chief Medical Officer

2 sales — total 31,138 USD

Planned sale 23 Feb 2026

Value US$15,568.90 | Price 7.45 | Shares 2,089

Proposed sale 23 Feb 2026

Value US$15,568.90 | Price 7.45 | Shares 2,089

de Verneuil Vanina

EVP, General Counsel, Corp Sec

2 sales — total 66,255 USD

Planned sale 23 Feb 2026

Value US$33,127.70 | Price 7.45 | Shares 4,445

Proposed sale 23 Feb 2026

Value US$33,127.70 | Price 7.45 | Shares 4,445

De Backer Marianne

Chief Executive Officer

2 sales — total 283,788 USD

Planned sale 23 Feb 2026

Value US$141,893.86 | Price 7.45 | Shares 19,039

Proposed sale 23 Feb 2026

Value US$141,893.86 | Price 7.45 | Shares 19,039

Sabatini Brent

SVP, Chief Accounting Officer

2 sales — total 23,837 USD

Planned sale 13 Feb 2026

Value US$11,918.70 | Price 7.79 | Shares 1,530

Proposed sale 13 Feb 2026

Value US$11,918.09 | Price 7.79 | Shares 1,530

SATO VICKI L

1 sale — total 169,671 USD

Planned sale 2 Feb 2026

Value US$169,670.60 | Price 7.71 | Shares 22,000

SVF Endurance (Cayman) Limited

Stockholder

1 sale — total 8,533,886 USD

Proposed sale 14 Jan 2026

Value US$8,533,886.46 | Price 6.82 | Shares 1,251,303

SATO VICKI L

1 sale — total 130,383 USD

Planned sale 2 Jan 2026

Value US$130,383.00 | Price 5.93 | Shares 22,000

VICKI LEE SATO

Director

1 sale — total 397,980 USD

Proposed sale 2 Jan 2026

Value US$397,980.00 | Price 6.03 | Shares 66,000

SVF Endurance (Cayman) Ltd

1 sale — total 1,147,786 USD

Planned sale 1 Dec 2025

Value US$1,147,785.74 | Price 5.98 | Shares 191,854

SATO VICKI L

1 sale — total 132,070 USD

Planned sale 1 Dec 2025

Value US$132,070.40 | Price 6.00 | Shares 22,000

SVF Endurance (Cayman) Ltd

1 sale — total 396,015 USD

Planned sale 28 Nov 2025

Value US$396,014.92 | Price 6.44 | Shares 61,493

SVF Endurance (Cayman) Ltd

1 sale — total 817,652 USD

Planned sale 26 Nov 2025

Value US$817,651.76 | Price 6.39 | Shares 127,938

SVF Endurance (Cayman) Ltd

1 sale — total 1,505,495 USD

Planned sale 25 Nov 2025

Value US$1,505,494.98 | Price 6.38 | Shares 235,971

SVF Endurance (Cayman) Limited

10% Stockholder

1 sale — total 8,058,391 USD

Proposed sale 25 Nov 2025

Value US$8,058,391.32 | Price 6.44 | Shares 1,251,303

SVF Endurance (Cayman) Ltd

1 sale — total 1,400,783 USD

Planned sale 24 Nov 2025

Value US$1,400,783.43 | Price 6.15 | Shares 227,803

O'Byrne Jason

EVP & Chief Financial Officer

2 sales — total 75,563 USD

Sale 17 Nov 2025

Value US$37,782.04 | Price 5.56 | Shares 6,799

Proposed sale 17 Nov 2025

Value US$37,780.68 | Price 5.56 | Shares 6,799

de Verneuil Vanina

EVP, General Counsel, Corp Sec

2 sales — total 24,613 USD

Planned sale 5 Nov 2025

Value US$12,306.60 | Price 5.16 | Shares 2,385

Proposed sale 5 Nov 2025

Value US$12,306.60 | Price 5.16 | Shares 2,385

de Verneuil Vanina

EVP and General Counsel

2 sales — total 16,006 USD

Sale 3 Nov 2025

Value US$8,003.00 | Price 5.86 | Shares 1,365

Proposed sale 3 Nov 2025

Value US$8,003.00 | Price 5.86 | Shares 1,365

SATO VICKI L

1 sale — total 124,047 USD

Planned sale 3 Nov 2025

Value US$124,047.00 | Price 5.64 | Shares 22,000

SVF Endurance (Cayman) Ltd

1 sale — total 649 USD

Planned sale 29 Oct 2025

Value US$649.00 | Price 6.49 | Shares 100

SVF Endurance (Cayman) Ltd

1 sale — total 159,006 USD

Planned sale 28 Oct 2025

Value US$159,005.63 | Price 6.50 | Shares 24,453

SVF Endurance (Cayman) Ltd

1 sale — total 401,585 USD

Planned sale 27 Oct 2025

Value US$401,585.42 | Price 6.05 | Shares 66,403

SVF Endurance (Cayman) Ltd

1 sale — total 278,285 USD

Planned sale 24 Oct 2025

Value US$278,284.81 | Price 5.96 | Shares 46,696

SVF Endurance (Cayman) Ltd

1 sale — total 924,723 USD

Planned sale 23 Oct 2025

Value US$924,723.29 | Price 5.99 | Shares 154,383

SVF Endurance (Cayman) Ltd

1 sale — total 887,654 USD

Planned sale 22 Oct 2025

Value US$887,654.27 | Price 6.15 | Shares 144,266

SVF Endurance (Cayman) Ltd

1 sale — total 690,974 USD

Planned sale 21 Oct 2025

Value US$690,974.44 | Price 6.30 | Shares 109,675

SVF Endurance (Cayman) Limited

10% Stockholder

1 sale — total 5,230,447 USD

Proposed sale 21 Oct 2025

Value US$5,230,446.54 | Price 6.27 | Shares 834,202

SVF Endurance (Cayman) Ltd

1 sale — total 1,367,273 USD

Planned sale 20 Oct 2025

Value US$1,367,272.89 | Price 6.20 | Shares 220,535

SVF Endurance (Cayman) Ltd

1 sale — total 78,366 USD

Planned sale 16 Oct 2025

Value US$78,366.38 | Price 6.10 | Shares 12,844

SVF Endurance (Cayman) Ltd

1 sale — total 101,196 USD

Planned sale 15 Oct 2025

Value US$101,196.30 | Price 6.07 | Shares 16,671

SVF Endurance (Cayman) Ltd

1 sale — total 13,973 USD

Planned sale 10 Oct 2025

Value US$13,972.96 | Price 6.08 | Shares 2,300

SVF Endurance (Cayman) Ltd

1 sale — total 1,529,926 USD

Planned sale 9 Oct 2025

Value US$1,529,925.77 | Price 6.14 | Shares 249,060

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-06-02	2026-06-01	PlS Planned sale	Napolitano Janet Non-Executive Director	18,706 -1.4% 279.75 US$3,120,488	18,706 -1.4%	279.75	US$3,120,488
2026-06-02	2026-06-01	PlS Planned sale	3.7 Sabatini Brent SVP, Chief Accounting Officer Officer	5,417 +6.3% 448.32 US$4,309,715	5,417 +6.3%	448.32	US$4,309,715
2026-06-01	2026-06-01	PrS Proposed sale	3.7 Sabatini Brent Officer Officer	22,071 426.18 US$4,968,237	22,071	426.18	US$4,968,237
2026-06-01	2026-06-01	PrS Proposed sale	Napolitano Janet Director Non-Executive Director	3,200 9.45 US$30,240	3,200	9.45	US$30,240
2026-05-04	2026-05-01	PlS Planned sale	SATO VICKI L Non-Executive Director	22,000 -2.0% 10.05 US$221,025	22,000 -2.0%	10.05	US$221,025
2026-04-30	2026-04-30	PrS Proposed sale	4.0 Eisner Mark Former Officer Officer	88,958 10.30 US$916,267	88,958	10.30	US$916,267
2026-04-07	2026-04-06	PlS Planned sale	3.5 De Backer Marianne President and CEO Executive Director	72,559 -7.1% 9.16 US$664,350	72,559 -7.1%	9.16	US$664,350
2026-04-06	2026-04-06	PrS Proposed sale	3.5 De Backer Marianne Officer; Director Executive Director	72,559 9.16 US$664,343	72,559	9.16	US$664,343
2026-04-02	2026-04-01	PlS Planned sale	SATO VICKI L Non-Executive Director	22,000 -2.0% 9.07 US$199,617	22,000 -2.0%	9.07	US$199,617
2026-03-24	2026-03-23	PlS Planned sale	3.7 Sabatini Brent SVP, Chief Accounting Officer Officer	7,711 -11.1% 9.12 US$70,324	7,711 -11.1%	9.12	US$70,324
2026-03-23	2026-03-23	PrS Proposed sale	3.7 Sabatini Brent Officer Officer	7,711 9.12 US$70,324	7,711	9.12	US$70,324
2026-03-03	2026-03-02	PlS Planned sale	SATO VICKI L Non-Executive Director	200 -0.0% 9.98 US$1,996	200 -0.0%	9.98	US$1,996
2026-03-03	2026-03-02	PlS Planned sale	SATO VICKI L Non-Executive Director	21,800 -1.9% 9.50 US$207,185	21,800 -1.9%	9.50	US$207,185
2026-03-02	2026-03-02	PrS Proposed sale	VICKI LEE SATO Director Non-Executive Director	88,000 9.09 US$799,920	88,000	9.09	US$799,920
2026-02-26	2026-02-25	PlS Planned sale	4.0 Eisner Mark EVP and Chief Medical Officer Officer	1,889 -1.2% 9.82 US$18,550	1,889 -1.2%	9.82	US$18,550
2026-02-26	2026-02-25	PlS Planned sale	3.7 de Verneuil Vanina EVP, General Counsel, Corp Sec Officer	13,700 -10.8% 9.82 US$134,534	13,700 -10.8%	9.82	US$134,534
2026-02-25	2026-02-25	PrS Proposed sale	3.3 SVF Endurance (Cayman) Limited Stockholder Large shareholder	400,000 9.49 US$3,796,000	400,000	9.49	US$3,796,000
2026-02-25	2026-02-25	PrS Proposed sale	3.7 de Verneuil Vanina Officer Officer	13,700 9.82 US$134,534	13,700	9.82	US$134,534
2026-02-25	2026-02-25	PrS Proposed sale	4.0 Eisner Mark Officer Officer	1,889 9.82 US$18,550	1,889	9.82	US$18,550
2026-02-26	2026-02-24	PlS Planned sale	0.5 O'Byrne Jason EVP & Chief Financial Officer Officer	1,634 -1.0% 9.53 US$15,576	1,634 -1.0%	9.53	US$15,576
2026-02-26	2026-02-24	PlS Planned sale	SATO VICKI L Non-Executive Director	200 -0.0% 10.26 US$2,052	200 -0.0%	10.26	US$2,052
2026-02-26	2026-02-24	PlS Planned sale	SATO VICKI L Non-Executive Director	42,177 -3.6% 9.75 US$411,314	42,177 -3.6%	9.75	US$411,314
2026-02-26	2026-02-24	PlS Planned sale	3.7 Sabatini Brent SVP, Chief Accounting Officer Officer	1,430 -2.0% 9.53 US$13,632	1,430 -2.0%	9.53	US$13,632
2026-02-26	2026-02-24	PlS Planned sale	4.0 Eisner Mark EVP and Chief Medical Officer Officer	1,616 -1.0% 9.53 US$15,405	1,616 -1.0%	9.53	US$15,405
2026-02-26	2026-02-24	PlS Planned sale	3.7 de Verneuil Vanina EVP, General Counsel, Corp Sec Officer	3,117 -2.4% 9.53 US$29,713	3,117 -2.4%	9.53	US$29,713
2026-02-26	2026-02-24	PlS Planned sale	3.5 De Backer Marianne Chief Executive Officer Executive Director	14,762 -1.4% 9.53 US$140,720	14,762 -1.4%	9.53	US$140,720
2026-02-24	2026-02-24	PrS Proposed sale	4.0 Eisner Mark Officer Officer	1,616 9.53 US$15,405	1,616	9.53	US$15,405
2026-02-24	2026-02-24	PrS Proposed sale	3.5 De Backer Marianne Officer; Director Executive Director	14,762 9.53 US$140,720	14,762	9.53	US$140,720
2026-02-24	2026-02-24	PrS Proposed sale	0.5 O'Byrne Jason Officer Officer	1,634 9.53 US$15,576	1,634	9.53	US$15,576
2026-02-24	2026-02-24	PrS Proposed sale	3.7 Sabatini Brent Officer Officer	1,430 9.53 US$13,632	1,430	9.53	US$13,632
2026-02-24	2026-02-24	PrS Proposed sale	3.7 de Verneuil Vanina Officer Officer	3,117 9.53 US$29,713	3,117	9.53	US$29,713
2026-02-24	2026-02-24	PrS Proposed sale	VICKI LEE SATO Director Non-Executive Director	20,377 7.43 US$151,401	20,377	7.43	US$151,401
2026-02-24	2026-02-23	PlS Planned sale	3.7 Sabatini Brent SVP, Chief Accounting Officer Officer	1,829 -2.5% 7.45 US$13,631	1,829 -2.5%	7.45	US$13,631
2026-02-24	2026-02-23	PlS Planned sale	0.5 O'Byrne Jason EVP & Chief Financial Officer Officer	2,089 -1.3% 7.45 US$15,569	2,089 -1.3%	7.45	US$15,569
2026-02-24	2026-02-23	PlS Planned sale	4.0 Eisner Mark EVP and Chief Medical Officer Officer	2,089 -1.3% 7.45 US$15,569	2,089 -1.3%	7.45	US$15,569
2026-02-24	2026-02-23	PlS Planned sale	3.7 de Verneuil Vanina EVP, General Counsel, Corp Sec Officer	4,445 -3.3% 7.45 US$33,128	4,445 -3.3%	7.45	US$33,128
2026-02-24	2026-02-23	PlS Planned sale	3.5 De Backer Marianne Chief Executive Officer Executive Director	19,039 -1.8% 7.45 US$141,894	19,039 -1.8%	7.45	US$141,894
2026-02-23	2026-02-23	PrS Proposed sale	0.5 O'Byrne Jason Officer Officer	2,089 7.45 US$15,569	2,089	7.45	US$15,569
2026-02-23	2026-02-23	PrS Proposed sale	4.0 Eisner Mark Officer Officer	2,089 7.45 US$15,569	2,089	7.45	US$15,569
2026-02-23	2026-02-23	PrS Proposed sale	3.5 De Backer Marianne Officer; Director Executive Director	19,039 7.45 US$141,894	19,039	7.45	US$141,894
2026-02-23	2026-02-23	PrS Proposed sale	3.7 de Verneuil Vanina Officer Officer	4,445 7.45 US$33,128	4,445	7.45	US$33,128
2026-02-23	2026-02-23	PrS Proposed sale	3.7 Sabatini Brent Officer Officer	1,829 7.45 US$13,631	1,829	7.45	US$13,631
2026-02-18	2026-02-13	PlS Planned sale	3.7 Sabatini Brent SVP, Chief Accounting Officer Officer	1,530 -3.1% 7.79 US$11,919	1,530 -3.1%	7.79	US$11,919
2026-02-13	2026-02-13	PrS Proposed sale	3.7 Sabatini Brent Officer Officer	1,530 7.79 US$11,918	1,530	7.79	US$11,918
2026-02-03	2026-02-02	PlS Planned sale	SATO VICKI L Non-Executive Director	22,000 -1.9% 7.71 US$169,671	22,000 -1.9%	7.71	US$169,671
2026-01-14	2026-01-14	PrS Proposed sale	3.3 SVF Endurance (Cayman) Limited Stockholder Large shareholder	1,251,303 6.82 US$8,533,886	1,251,303	6.82	US$8,533,886
2026-01-05	2026-01-02	PlS Planned sale	SATO VICKI L Non-Executive Director	22,000 -1.9% 5.93 US$130,383	22,000 -1.9%	5.93	US$130,383
2026-01-02	2026-01-02	PrS Proposed sale	VICKI LEE SATO Director Non-Executive Director	66,000 6.03 US$397,980	66,000	6.03	US$397,980
2025-12-03	2025-12-01	PlS Planned sale	3.3 SVF Endurance (Cayman) Ltd Large shareholder	191,854 -1.4% 5.98 US$1,147,786	191,854 -1.4%	5.98	US$1,147,786
2025-12-02	2025-12-01	PlS Planned sale	SATO VICKI L Non-Executive Director	22,000 -1.8% 6.00 US$132,070	22,000 -1.8%	6.00	US$132,070
2025-12-01	2025-11-28	PlS Planned sale	3.3 SVF Endurance (Cayman) Ltd Large shareholder	61,493 -0.4% 6.44 US$396,015	61,493 -0.4%	6.44	US$396,015
2025-12-01	2025-11-26	PlS Planned sale	3.3 SVF Endurance (Cayman) Ltd Large shareholder	127,938 -0.9% 6.39 US$817,652	127,938 -0.9%	6.39	US$817,652
2025-11-26	2025-11-25	PlS Planned sale	3.3 SVF Endurance (Cayman) Ltd Large shareholder	235,971 -1.6% 6.38 US$1,505,495	235,971 -1.6%	6.38	US$1,505,495
2025-11-25	2025-11-25	PrS Proposed sale	3.3 SVF Endurance (Cayman) Limited 10% Stockholder Large shareholder	1,251,303 6.44 US$8,058,391	1,251,303	6.44	US$8,058,391
2025-11-26	2025-11-24	PlS Planned sale	3.3 SVF Endurance (Cayman) Ltd Large shareholder	227,803 -1.6% 6.15 US$1,400,783	227,803 -1.6%	6.15	US$1,400,783
2025-11-18	2025-11-17	S Sale	0.5 O'Byrne Jason EVP & Chief Financial Officer Officer	6,799 -5.8% 5.56 US$37,782	6,799 -5.8%	5.56	US$37,782
2025-11-17	2025-11-17	PrS Proposed sale	0.5 O'Byrne Jason Officer Officer	6,799 5.56 US$37,781	6,799	5.56	US$37,781
2025-11-07	2025-11-05	PlS Planned sale	3.7 de Verneuil Vanina EVP, General Counsel, Corp Sec Officer	2,385 -3.0% 5.16 US$12,307	2,385 -3.0%	5.16	US$12,307
2025-11-05	2025-11-05	PrS Proposed sale	3.7 de Verneuil Vanina Officer Officer	2,385 5.16 US$12,307	2,385	5.16	US$12,307
2025-11-04	2025-11-03	S Sale	3.7 de Verneuil Vanina EVP and General Counsel Officer	1,365 -1.7% 5.86 US$8,003	1,365 -1.7%	5.86	US$8,003
2025-11-04	2025-11-03	PlS Planned sale	SATO VICKI L Non-Executive Director	22,000 -1.8% 5.64 US$124,047	22,000 -1.8%	5.64	US$124,047
2025-11-03	2025-11-03	PrS Proposed sale	3.7 de Verneuil Vanina Officer Officer	1,365 5.86 US$8,003	1,365	5.86	US$8,003
2025-10-30	2025-10-29	PlS Planned sale	3.3 SVF Endurance (Cayman) Ltd Large shareholder	100 -0.0% 6.49 US$649	100 -0.0%	6.49	US$649
2025-10-30	2025-10-28	PlS Planned sale	3.3 SVF Endurance (Cayman) Ltd Large shareholder	24,453 -0.2% 6.50 US$159,006	24,453 -0.2%	6.50	US$159,006
2025-10-28	2025-10-27	PlS Planned sale	3.3 SVF Endurance (Cayman) Ltd Large shareholder	66,403 -0.5% 6.05 US$401,585	66,403 -0.5%	6.05	US$401,585
2025-10-28	2025-10-24	PlS Planned sale	3.3 SVF Endurance (Cayman) Ltd Large shareholder	46,696 -0.3% 5.96 US$278,285	46,696 -0.3%	5.96	US$278,285
2025-10-24	2025-10-23	PlS Planned sale	3.3 SVF Endurance (Cayman) Ltd Large shareholder	154,383 -1.0% 5.99 US$924,723	154,383 -1.0%	5.99	US$924,723
2025-10-24	2025-10-22	PlS Planned sale	3.3 SVF Endurance (Cayman) Ltd Large shareholder	144,266 -1.0% 6.15 US$887,654	144,266 -1.0%	6.15	US$887,654
2025-10-22	2025-10-21	PlS Planned sale	3.3 SVF Endurance (Cayman) Ltd Large shareholder	109,675 -0.7% 6.30 US$690,974	109,675 -0.7%	6.30	US$690,974
2025-10-21	2025-10-21	PrS Proposed sale	3.3 SVF Endurance (Cayman) Limited 10% Stockholder Large shareholder	834,202 6.27 US$5,230,447	834,202	6.27	US$5,230,447
2025-10-22	2025-10-20	PlS Planned sale	3.3 SVF Endurance (Cayman) Ltd Large shareholder	220,535 -1.4% 6.20 US$1,367,273	220,535 -1.4%	6.20	US$1,367,273
2025-10-17	2025-10-16	PlS Planned sale	3.3 SVF Endurance (Cayman) Ltd Large shareholder	12,844 -0.1% 6.10 US$78,366	12,844 -0.1%	6.10	US$78,366
2025-10-17	2025-10-15	PlS Planned sale	3.3 SVF Endurance (Cayman) Ltd Large shareholder	16,671 -0.1% 6.07 US$101,196	16,671 -0.1%	6.07	US$101,196
2025-10-14	2025-10-10	PlS Planned sale	3.3 SVF Endurance (Cayman) Ltd Large shareholder	2,300 -0.0% 6.08 US$13,973	2,300 -0.0%	6.08	US$13,973
2025-10-14	2025-10-09	PlS Planned sale	3.3 SVF Endurance (Cayman) Ltd Large shareholder	249,060 -1.6% 6.14 US$1,529,926	249,060 -1.6%	6.14	US$1,529,926

Explore more

More insider trading research around Vir Biotechnology Inc

More insider trades in United States

Similar Healthcare companies with insider activity

More Pharmaceuticals & Medical Research companies with insider activity

More Biotechnology & Medical Research companies with insider activity

Insider trading in North America

Vir Biotechnology Inc (VIR)

Track

Featured in screeners

Stock chart

Transactions

Insider

Sort by

Trades

Explore more